Lipocine (LPCN) Prevails in LPCN 1021 Patent Suit
Tweet Send to a Friend
Lipocine Inc. (Nasdaq: LPCN) announced that U.S. District Court in Delaware granted our motion to dismiss a lawsuit filed by ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE